Suppr超能文献

评估 HPV 病毒载量和 16/18 基因型分型联合检测在二级筛查算法中的应用。

Evaluation of alternately combining HPV viral load and 16/18 genotyping in secondary screening algorithms.

机构信息

Department of Obstetrics and Gynecology, Peking University People' Hospital, Beijing, PR China.

Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, PR China.

出版信息

PLoS One. 2019 Jul 26;14(7):e0220200. doi: 10.1371/journal.pone.0220200. eCollection 2019.

Abstract

BACKGROUND

Correlation with HPV viral load and worsening cervical lesions had been reported, but its potential for triage after primary HPV screening has not been adequately explored, especially when combined with HPV-16/18 genotyping.

OBJECTIVE

To evaluate combinations of human papillomavirus (HPV) viral load and genotyping for HPV-16/18 as secondary screening strategies.

METHODS

The Shenzhen Cervical Cancer Screening Trial Ⅱ (SHENCCAST Ⅱ) database was re-analyzed to explore new screening algorithms using the results of Hybrid Capture 2 (HC2), Mass Array Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass spectrometry System (MALDI-TOF-MS) and the ThinPrep cytologic test (TCT) obtained by endocervical sampling.

RESULTS

Compared with the recommended screening strategy of genotyping HPV-16/18 plus reflex to cytology, using viral load (10 RLU/CO as threshold) plus reflex to cytology resulted in less cytology but had a significantly higher sensitivity for cervical intraepithelial neoplasia 2+ (CIN2+)/CIN3+ without considerable changes in specificity and referral rates. Both of the strategy of using viral load ≥10 RLU/CO as cut-point for immediate colposcopy followed by triage genotyping HPV-16/18 for the other positive (≥1<10 RLU/CO) and the strategy of referring HPV-16/18 positives for immediate colposcopy followed by triage viral load (10 RLU/CO as threshold) for non-HPV-16/18 positives had comparable screening efficacy with algorithims that contain cytology.

CONCLUSIONS

Primary HPV screening with triage of HPV-positive women by a combination of viral load and genotyping for HPV-16/18 provides good balance between sensitivity and specificity, the number of tests required, and referral rates.

摘要

背景

已有研究报道 HPV 病毒载量与宫颈病变恶化相关,但 HPV 病毒载量在 HPV 初筛后的分流作用尚未得到充分探讨,特别是与 HPV-16/18 基因分型联合应用时。

目的

评估 HPV 病毒载量和 HPV-16/18 基因分型联合检测作为 HPV 初筛后二级筛查策略的应用价值。

方法

利用杂交捕获 2 代(HC2)、MALDI-TOF-MS 基因芯片技术和液基细胞学检测(TCT)对深圳市宫颈癌筛查研究Ⅱ(SHENCCAST Ⅱ)数据库进行再分析,探索新的筛查方案。

结果

与推荐的 HPV-16/18 基因分型联合细胞学检测的筛查策略相比,HPV 病毒载量(10 RLU/CO 为界值)联合细胞学检测策略可减少细胞学检查数量,但 CIN2+/CIN3+的敏感性显著提高,而特异性和转诊率无明显变化。HPV 病毒载量≥10 RLU/CO 者行阴道镜检查,其余 HPV 阳性(1<HPV 载量<10 RLU/CO)者行 HPV-16/18 基因分型检测,或 HPV 阳性者行阴道镜检查,HPV-16/18 阴性者行 HPV 病毒载量检测(10 RLU/CO 为界值)的筛查效果与包含细胞学检查的策略相当。

结论

HPV 初筛联合 HPV 病毒载量和 HPV-16/18 基因分型检测的分流方法具有较好的敏感性和特异性、检测数量和转诊率之间的平衡。

相似文献

引用本文的文献

本文引用的文献

9
The current position and the future perspectives of cervical cancer screening.宫颈癌筛查的现状与未来展望
Expert Rev Anticancer Ther. 2014 Jan;14(1):75-92. doi: 10.1586/14737140.2014.856273. Epub 2013 Nov 28.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验